These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10555694)

  • 1. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.
    Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo G; June CH; Levine B; Lum LG
    Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1229-34. PubMed ID: 10555694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma.
    Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo GH; June CH; Levine BL; Lum LG
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):473-9. PubMed ID: 10772300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-coated suture enhances immune response: important ideas emerge from multidisciplinary training.
    Whiteside TL
    Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1237-8. PubMed ID: 10555695
    [No Abstract]   [Full Text] [Related]  

  • 4. Covalent linking of proteins and cytokines to suture: enhancing the immune response of head and neck cancer patients.
    Shibuya TY; Kim S; Nguyen K; Parikh P; Wadhwa A; Brockardt C; Do J
    Laryngoscope; 2003 Nov; 113(11):1870-84. PubMed ID: 14603040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell responses in fresh and cryopreserved peripheral blood mononuclear cells: kinetics of cell viability, cellular subsets, proliferation, and cytokine production.
    Jeurink PV; Vissers YM; Rappard B; Savelkoul HF
    Cryobiology; 2008 Oct; 57(2):91-103. PubMed ID: 18593572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive suture: a novel immunotherapy for head and neck cancer.
    Shibuya TY; Kim S; Nguyen K; Do J; McLaren CE; Li KT; Chen WP; Parikh P; Wadhwa A; Zi X; Chen VY; Wong HS; Armstrong WB; Yoo GH
    Clin Cancer Res; 2004 Oct; 10(20):7088-99. PubMed ID: 15501989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro induction of regulatory T cells by anti-CD3 antibody in humans.
    Abraham M; Karni A; Dembinsky A; Miller A; Gandhi R; Anderson D; Weiner HL
    J Autoimmun; 2008; 30(1-2):21-8. PubMed ID: 18191540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells-phase I clinical trial.
    Lum LG; LeFever AV; Treisman JS; Garlie NK; Hanson JP
    J Immunother; 2001; 24(5):408-19. PubMed ID: 11696696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies.
    Harada M; Okamoto T; Omoto K; Tamada K; Takenoyama M; Hirashima C; Ito O; Kimura G; Nomoto K
    Immunology; 1996 Mar; 87(3):447-53. PubMed ID: 8778032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation.
    Arrington JL; Chapkin RS; Switzer KC; Morris JS; McMurray DN
    Clin Exp Immunol; 2001 Sep; 125(3):499-507. PubMed ID: 11531960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of poor CD3 response in head and neck cancer.
    Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W
    Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.
    Junker N; Andersen MH; Wenandy L; Dombernowsky SL; Kiss K; Sørensen CH; Therkildsen MH; Von Buchwald C; Andersen E; Straten PT; Svane IM
    Cytotherapy; 2011 Aug; 13(7):822-34. PubMed ID: 21428850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
    Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
    PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
    Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
    Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of tumor reactive CD4+ cells generated from tumor-primed lymph nodes using anti-CD3/anti-CD28 monoclonal antibodies.
    Li Q; Yu B; Grover AC; Zeng X; Chang AE
    J Immunother; 2002; 25(4):304-13. PubMed ID: 12142553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naive human T-cells become non-responsive towards anti-TNFalpha (infliximab) treatment in vitro if co-stimulated through CD28.
    Gunnlaugsdottir B; Skaftadottir I; Ludviksson BR
    Scand J Immunol; 2008 Dec; 68(6):624-34. PubMed ID: 19000096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
    Bohlen H; Hopff T; Manzke O; Engert A; Kube D; Wickramanayake PD; Diehl V; Tesch H
    Blood; 1993 Sep; 82(6):1803-12. PubMed ID: 7691238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte stimulation by CD3-CD28 enables detection of low T cell interferon-gamma and interleukin-4 production in rheumatoid arthritis.
    Verhoef CM; Van Roon JA; Vianen ME; Glaudemans CA; Lafeber FP; Bijlsma JW
    Scand J Immunol; 1999 Oct; 50(4):427-32. PubMed ID: 10520184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.